Cannabix Technologies Inc. (BLOZF)
USD 0.24
(0.42%)
USD 0.24
(0.42%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | 12.7 Thousand CAD | 0.0% |
| 2023 | 11.53 Thousand CAD | 0.0% |
| 2022 | - CAD | 0.0% |
| 2021 | - CAD | 0.0% |
| 2020 | - CAD | 0.0% |
| 2019 | - CAD | 0.0% |
| 2018 | - CAD | 0.0% |
| 2017 | - CAD | 0.0% |
| 2016 | - CAD | 0.0% |
| 2015 | - CAD | 0.0% |
| 2014 | - CAD | 0.0% |
| 2013 | - CAD | 0.0% |
| 2012 | - CAD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | - CAD | 0.0% |
| 2024 FY | 12.7 Thousand CAD | 10.15% |
| 2024 Q3 | - CAD | 0.0% |
| 2024 Q4 | 12.7 Thousand CAD | 0.0% |
| 2024 Q1 | - CAD | 0.0% |
| 2023 Q3 | - CAD | 0.0% |
| 2023 Q4 | 11.53 Thousand CAD | 0.0% |
| 2023 FY | 11.53 Thousand CAD | 0.0% |
| 2023 Q1 | - CAD | 0.0% |
| 2023 Q2 | - CAD | 0.0% |
| 2022 Q2 | - CAD | 0.0% |
| 2022 Q1 | - CAD | 0.0% |
| 2022 FY | - CAD | 0.0% |
| 2022 Q4 | - CAD | 0.0% |
| 2022 Q3 | - CAD | 0.0% |
| 2021 Q3 | - CAD | 0.0% |
| 2021 Q2 | - CAD | 0.0% |
| 2021 Q1 | - CAD | 0.0% |
| 2021 FY | - CAD | 0.0% |
| 2021 Q4 | - CAD | 0.0% |
| 2020 Q1 | - CAD | 0.0% |
| 2020 FY | - CAD | 0.0% |
| 2020 Q3 | - CAD | 0.0% |
| 2020 Q4 | - CAD | 0.0% |
| 2020 Q2 | - CAD | 0.0% |
| 2019 Q2 | - CAD | 0.0% |
| 2019 Q3 | - CAD | 0.0% |
| 2019 Q4 | - CAD | 0.0% |
| 2019 FY | - CAD | 0.0% |
| 2019 Q1 | - CAD | 0.0% |
| 2018 Q2 | - CAD | 0.0% |
| 2018 Q1 | - CAD | 0.0% |
| 2018 Q4 | - CAD | 0.0% |
| 2018 FY | - CAD | 0.0% |
| 2018 Q3 | - CAD | 0.0% |
| 2017 FY | - CAD | 0.0% |
| 2017 Q1 | - CAD | 0.0% |
| 2017 Q4 | - CAD | 0.0% |
| 2017 Q3 | - CAD | 0.0% |
| 2017 Q2 | - CAD | 0.0% |
| 2016 Q1 | - CAD | 0.0% |
| 2016 Q4 | - CAD | 0.0% |
| 2016 FY | - CAD | 0.0% |
| 2016 Q3 | - CAD | 0.0% |
| 2016 Q2 | - CAD | 0.0% |
| 2015 Q3 | - CAD | 0.0% |
| 2015 Q1 | - CAD | 0.0% |
| 2015 FY | - CAD | 0.0% |
| 2015 Q4 | - CAD | 0.0% |
| 2015 Q2 | - CAD | 0.0% |
| 2014 Q1 | - CAD | 0.0% |
| 2014 Q2 | - CAD | 0.0% |
| 2014 FY | - CAD | 0.0% |
| 2014 Q4 | - CAD | 0.0% |
| 2014 Q3 | - CAD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| 2013 Q4 | - CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| AVITA Medical, Inc. | 449.48 Thousand USD | 97.174% |
| Manhattan Scientifics, Inc. | - USD | -Infinity% |
| Össur hf. | 311.8 Million USD | 99.996% |
| QHSLab, Inc. | - USD | -Infinity% |
| Wellstar International, Inc. | 18.86 Million USD | 99.933% |
| Össur hf. | 311.8 Million USD | 99.996% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 279.4 Thousand USD | 95.454% |
| Aurora Spine Corporation | 1.59 Million USD | 99.202% |
| BrainsWay Ltd. | 239 Thousand USD | 94.685% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | 12.52 Million USD | 99.899% |
| Hamilton Thorne Ltd. | 16.7 Million USD | 99.924% |
| Vivos Inc. | - USD | -Infinity% |
| Kelyniam Global, Inc. | 217.61 Thousand USD | 94.163% |
| REMSleep Holdings, Inc. | 43.67 Thousand USD | 70.918% |
| Zecotek Photonics Inc. | - USD | -Infinity% |
| Avitar, Inc. | 3.89 Million USD | 99.674% |
| Nanomix Corporation | 10.11 Million USD | 99.874% |
| EKF Diagnostics Holdings plc | 618 Thousand USD | 97.945% |
| Theraclion SA | 1.95 Million EUR | 99.349% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | - USD | -Infinity% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 150 Thousand USD | 91.532% |
| Lombard Medical, Inc. | 28.02 Million USD | 99.955% |
| ALR Technologies Inc. | - USD | -Infinity% |
| Stratec SE | 89.25 Million USD | 99.986% |
| Vycor Medical, Inc. | 243.28 Thousand USD | 94.779% |
| Heart Tronics, Inc. | - USD | -Infinity% |
| MicroPort Scientific Corporation | 814.21 Million USD | 99.998% |
| VMS Rehab Systems, Inc. | 106.45 USD | -11832.363% |
| NewCardio, Inc. | - USD | -Infinity% |
| Guided Therapeutics, Inc. | 511 Thousand USD | 97.514% |
| Ingen Technologies, Inc. | 532.27 Thousand USD | 97.614% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| CYduct Diagnostics, Inc. | 590 Thousand USD | 97.847% |
| Wellness Center USA, Inc. | 304.6 Thousand USD | 95.83% |
| SANUWAVE Health, Inc. | 492 Thousand USD | 97.418% |
| IR-Med Inc. | 161 Thousand USD | 92.111% |
| Perimeter Medical Imaging AI, Inc. | 142.32 Thousand USD | 91.076% |
| Polarean Imaging plc | 74.84 Thousand USD | 83.029% |
| United American Healthcare Corporation | - USD | -Infinity% |
| ECGI Holdings, Inc. | 804 Thousand USD | 98.42% |
| Nu-Med Plus, Inc. | - USD | -Infinity% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 322.4 Thousand USD | 96.06% |
| Medical Supply International USA, Inc. | 116.05 Thousand USD | 89.055% |
| Urologix, Inc. | 4.58 Million USD | 99.723% |
| Rapid Therapeutic Science Laboratories, Inc. | 430.23 Thousand USD | 97.048% |
| Nexeon MedSystems Inc. | 2.78 Million USD | 99.544% |
| SS Innovations International, Inc. | 1.91 Million USD | 99.335% |
| Qualis Innovations, Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 2.17 Billion USD | 99.999% |
| NIOX Group Plc | 500 Thousand USD | 97.46% |
| Fuse Medical, Inc. | 200 Thousand USD | 93.649% |
| Broncus Holding Corporation | 1.22 Million USD | 98.962% |
| Brain Scientific Inc. | 7378.00 USD | -72.16% |
| Pressure BioSciences, Inc. | 161.86 Thousand USD | 92.153% |
| Health Logic Interactive Inc. | - USD | -Infinity% |